Table 1.
Category | Compound | Action/Use | Reference |
---|---|---|---|
Established antifungals | |||
Amphotericin B | Interaction with ergosterol to form transmembrane channels [81, 82] | [59] | |
Bifonazole | Interference with ergosterol synthesis [83] | [59] | |
Butoconazole nitrate | Interference with ergosterol synthesis [84, 85] | [59] | |
Ketoconazole | Interference with ergosterol synthesis [83] | [59] | |
Nystatin | Binding to ergosterol to induce permeability changes [86] | [59] | |
Oxiconazole nitrate | Interference with ergosterol synthesis [84, 87] | [59] | |
Terconazole | Interference with ergosterol synthesis [88] | [59] | |
Immunosuppressant agents | |||
Ascomycin (Ethyl analogue of FK-506) |
Binding to immunophilins and inhibition of Th1 & Th2 cytokine production [89] | [59] | |
Cyclosporin A | Complex formation with cyclophilin to inhibit calcineurin [90] | [59] | |
FK-506 (Tacrolimus) | Complex formation with FKBP-12 to inhibit calcineurin [91, 92] | [59] | |
Plant-derived saponin natural products | |||
A2 Sakurasosaponin | Molluscicidal and antifungal triterpenoid saponin [93] | [62] | |
A6 Arvensoside B | No previous reports on antifungal activity | [62] | |
A7 | No previous reports on antifungal activity | [62] | |
A8 (Analogue of A16) | Glycosylated derivative of Aginoside [94, 95] | [62] | |
All | No previous reports on antifungal activity | [62] | |
A16 Aginoside | Known antifungal natural product [94, 95] | [62] | |
A17 | Pentasaccharide that incorporates the distal furanose residue, related to maesabalide family; no reports on antifungal activity [96] |
[62] | |
A19 | Related to barrigenol family, unique polyglycosylation [97,98] | [62] | |
A20 | No previous reports on antifungal activity | [62] | |
A21 | Pentasaccharide that incorporates the distal furanose residue, related to maesabalide family; no reports on antifungal activity [96] |
[62] | |
A24 (Analogue of A 16) | Glycosylated derivative of Aginoside [94, 95] | [62] | |
A25 | Related to barrigenol family, unique polyglycosylation; excellent activity against C. albicans in vitro [97] |
[62] | |
Other compounds | |||
Caffeic acid phenethyl ester (CAPE) |
Active component of propolis, a natural antimicrobial resinous plant product collected & used by honeybees for protection of hives [99] |
[49] | |
Concanamycin A | Potent & specific inhibition of vacuolar-ATPase [100] | [59] | |
Dequalinium chloride | Potent anti-tumor activity and protein kinase C alpha (PKC) inhibition [101] | [59] | |
Ellipticine | Potent anti-tumor agent; DNA intercalation and/or topoisomerase II inhibition [102] | [59] | |
Enoxacin | Fluoroquinolone antibiotic; enhancement of in vitro antifungal activity of amphotericin B & mepartricin; no inhibition of filament formation in C. elegans-killing assay [103] |
[49] | |
Lapachol | Naphthoquinone found in tropical plant seeds & heartwood; anti-leishmanicidal activity [104, 105] |
[49] | |
Malachite green carbinol base |
Metabolism to carbinol form, then to toxic leucomalachite green form; used for parasitic, fungal & bacterial infections in fish & fish eggs [106, 107] |
[59] | |
Mepartricin | Used to treat chronic pelvic pain syndrome; reduction of estrogen plasma levels & their con- centration in the prostrate; antifungal activity against Candida [108] |
[59] | |
Phenylmercuric acetate | Metabolism to diphenylmercury; used as fungicide, herbicide, slimicide & bacteriocide [109] | [59] | |
Suloctidil | Used as a peripheral vasodilator, formerly in treating peripheral and cerebral vascular disor- ders; hepatotoxic [110] |
[59] | |
Triadimefon | Gibberellin & sterol biosynthesis [111] | [59] | |
Valinomycin | Apoptosis inducer by disruption of mitochondrial membrane potential; affects C. albicans morphology [112, 113] |
[59] |